Gastrointestinal endoscopy · 2026
Fluoroscopy-free direct solitary cholangioscopy versus endoscopic retrograde cholangiography for clearance of noncomplex biliary stones: a noninferiority randomized controlled trial.
СтатьяСравнительное исследованиеEquivalence TrialРандомизированное исследованиеПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Banerjee Subhas, Goenka Mahesh K, Ramchandani Mohan, Shah Raj J, Lakhtakia Sundeep, Ridtitid Wiriyaporn, Shah Janak N, Thosani Nirav, Wagh Mihir S, Costamagna Guido, Peetermans Joyce A, Rousseau Matthew J, Rerknimitr Rungsun
Аннотация
BACKGROUND AND AIMS: Endoscopic removal of noncomplex bile-duct stones is typically accomplished by endoscopic retrograde cholangiography (ERC), requiring fluoroscopy-associated radiation exposure. Fluoroscopy exposure must be limited or is unavailable for some high-risk patients. We conducted a direct comparison of the efficacy and safety of ERC versus fluoroscopy-free direct solitary cholangioscopy (DSC) for noncomplex bile-duct stone removal.
METHODS: Eligible patients were aged 18 years or older with noncomplex common bile-duct or common hepatic-duct stones. The primary outcome was complete stone clearance by ERC, validated by DSC, or by fluoroscopy-free DSC, validated by ERC. Secondary outcomes included (1) radiation exposure to the patient, (2) procedure duration, and (3) device- or procedure-related serious adverse events (SAEs) reported by 30 days.
RESULTS: Of the 250 patients randomized, 126 were assigned to ERC and 124 to DSC. The mean age was 52.0 years, and 100 (40.0%) patients were male. On an intention-to-treat basis, complete stone clearance was achieved in 112 patients (88.9%) undergoing ERC, and in 108 patients (87.1%) undergoing fluoroscopy-free DSC (between-group difference, 1.8%; 1-sided upper limit of 95% CI, 8.9%; noninferiority margin 10.0%; P = .029 for noninferiority). For ERC versus DSC, the median dose area product was 2106 versus 0 Gy cm2, and the median index procedure duration was 11.9 versus 22.1 minutes, respectively. Procedure-related SAEs occurred in 5 patients (4.0%) undergoing ERC and 7 patients (5.6%) undergoing DSC.
CONCLUSIONS: Clearance rates of noncomplex biliary stones and rates of SAEs were comparable for ERC versus fluoroscopy-free DSC, with lower exposure to fluoroscopy-associated radiation during DSC (ClinicalTrials.gov no. NCT03421340).
METHODS: Eligible patients were aged 18 years or older with noncomplex common bile-duct or common hepatic-duct stones. The primary outcome was complete stone clearance by ERC, validated by DSC, or by fluoroscopy-free DSC, validated by ERC. Secondary outcomes included (1) radiation exposure to the patient, (2) procedure duration, and (3) device- or procedure-related serious adverse events (SAEs) reported by 30 days.
RESULTS: Of the 250 patients randomized, 126 were assigned to ERC and 124 to DSC. The mean age was 52.0 years, and 100 (40.0%) patients were male. On an intention-to-treat basis, complete stone clearance was achieved in 112 patients (88.9%) undergoing ERC, and in 108 patients (87.1%) undergoing fluoroscopy-free DSC (between-group difference, 1.8%; 1-sided upper limit of 95% CI, 8.9%; noninferiority margin 10.0%; P = .029 for noninferiority). For ERC versus DSC, the median dose area product was 2106 versus 0 Gy cm2, and the median index procedure duration was 11.9 versus 22.1 minutes, respectively. Procedure-related SAEs occurred in 5 patients (4.0%) undergoing ERC and 7 patients (5.6%) undergoing DSC.
CONCLUSIONS: Clearance rates of noncomplex biliary stones and rates of SAEs were comparable for ERC versus fluoroscopy-free DSC, with lower exposure to fluoroscopy-associated radiation during DSC (ClinicalTrials.gov no. NCT03421340).